Clinical Trial Posts on Medivizor
Navigation Menu

Clinical Trial Posts on Medivizor

Looking for participants to test an experimental Keytruda-combination study treatment for Small Cell Neuroendocrine Prostate Cancer (SCNC)

Looking for participants to test an experimental Keytruda-combination study treatment for Small Cell Neuroendocrine Prostate Cancer (SCNC)

Posted by on Feb 15, 2021 in Prostate cancer | 0 comments

In a nutshell This clinical trial is evaluating the safety and effectiveness of an experimental treatment, BXCL701, in combination with pembrolizumab (Keytruda) for people with small cell neuroendocrine prostate cancer (SCNPCa). The main outcome to be measured will be the response rate to the study treatment.   The details Prostate cancer is the...

Read More

COVID-19 Vaccine Clinical Trials: “Part of something bigger than myself”

COVID-19 Vaccine Clinical Trials: “Part of something bigger than myself”

Posted by on Feb 1, 2021 in Blog, Coronavirus / COVID-19, Lung cancer | 0 comments

Barry Nelson, Patient Advisor at Brigham and Women’s Hospital Center for Patients and Families participated in a webinar on January 11 organized by  The Center for Health Education Research Service in Boston, Massachusetts. [1] During the webinar, Nelson described his experience as a cancer survivor.  “I was diagnosed with advanced lung cancer...

Read More

Looking for patients with HER-2 positive advanced breast cancer to trial an experimental treatment.

Looking for patients with HER-2 positive advanced breast cancer to trial an experimental treatment.

Posted by on Jan 28, 2021 in Breast cancer | 0 comments

In a nutshell This trial is aiming to examine the safety and effectiveness of an experimental treatment called BPX-063, a CAR-T cell treatment, in patients with advanced HER-2 positive breast cancer. The main outcomes to be measured are the maximum tolerated dose of BPX-603 and the antitumor activity. This trial is being carried out across the...

Read More

Looking for patients with breast reconstructions following breast surgery to trial a short radiation therapy

Looking for patients with breast reconstructions following breast surgery to trial a short radiation therapy

Posted by on Jan 28, 2021 in Breast cancer | 0 comments

In a nutshell This trial is looking to examine the use of radiation on a shorter schedule of 5 days in a row is a safe and effective way to prevent breast cancer (BC) from coming back in people who have had a mastectomy (surgical removal of the breast). The main outcomes that are to be measured are local and regional disease recurrence. This trial is to...

Read More

Looking for patients with relapsed or refractory multiple myeloma to trial a treatment combination

Looking for patients with relapsed or refractory multiple myeloma to trial a treatment combination

Posted by on Jan 28, 2021 in Multiple Myeloma | 0 comments

In a nutshell This trial is aiming to examine the effectiveness of combination therapy with venetoclax (Venclexta), daratumumab (Darzalex), and dexamethasone (Ozurdex) with or without bortezomib (Velcade) for unresponsive or relapsed multiple myeloma (MM). The main outcome that is to be measured is the response rate, time to response,...

Read More

Searching for patients to trial an experimental medication for advanced solid tumors.

Searching for patients to trial an experimental medication for advanced solid tumors.

Posted by on Jan 28, 2021 in Lung cancer | 0 comments

In a nutshell This trial is aiming to examine the safety and effectiveness of experimental treatment DF6002 alone or in combination with nivolumab (Opdivo) in the treatment of advanced solid tumors, including lung cancer. The main outcomes to be measured are drug toxicity and the response rate of patients to the drug. This trial is being carried out in...

Read More

Searching for patients to trial an experimental medication for advanced solid tumors.

Searching for patients to trial an experimental medication for advanced solid tumors.

Posted by on Jan 28, 2021 in Prostate cancer | 0 comments

In a nutshell This trial is aiming to examine the safety and effectiveness of experimental treatment DF6002 alone or in combination with nivolumab (Opdivo) in the treatment of advanced solid tumors, including prostate cancer. The main outcomes to be measured are drug toxicity and the response rate of patients to the drug. This trial is being carried out...

Read More

Seeking men with metastatic castration-resistant prostate cancer to trial a combination therapy

Seeking men with metastatic castration-resistant prostate cancer to trial a combination therapy

Posted by on Dec 15, 2020 in Prostate cancer | 0 comments

In a nutshell This trial is evaluating the effectiveness and safety of combining nivolumab (Opdivo) with docetaxel (Taxotere) and prednisone (Deltasone) in men with metastatic castration-resistant prostate cancer (mCRPC). The main outcomes to be evaluated will be survival without cancer worsening and overall survival. The details CRPC is a difficult...

Read More

Searching for patients with metastatic breast cancer to trial a targeted therapy

Searching for patients with metastatic breast cancer to trial a targeted therapy

Posted by on Dec 15, 2020 in Breast cancer | 0 comments

In a nutshell This phase 2 clinical trial is evaluating the safety and effectiveness of targeted therapy TAS-120 (futibatinib) alone or in combination with fulvestrant (Faslodex) in patients with metastatic breast cancer (mBC). The main outcomes to be evaluated will be the response rate and survival without cancer worsening. The details Breast...

Read More

Searching for participants with advanced non-small cell lung cancer to trial an experimental therapy

Searching for participants with advanced non-small cell lung cancer to trial an experimental therapy

Posted by on Dec 15, 2020 in Lung cancer | 0 comments

In a nutshell This trial is evaluating the safety and effectiveness of experimental treatment REGN5093 in patients with advanced non-small-cell lung cancer (NSCLC). The main outcomes to be evaluated will be the number of patients who experience side effects, the maximum dose without significant side effects, and response to treatment. This trial is...

Read More